LEADER 00000nam 22002658a 4500
001 99013829429
003 UkLCURL
008 070822s2007 nju 000 0 eng d
020 9781588298584|q(hbk.)
020 1588298582|q(hbk.)
035 (Uk)013829429
040 StDuBDS|beng|cStDuBDS
049 |jCU|k99013829429|lb|m-
050 4 RC 271 P75 C2
082 04 616.99404227|222
245 00 Cancer proteomics :|bfrom bench to bedside /|cedited by
Sayed S. Daoud.
260 Totowa, N.J. :|bHumana,|cc2008.
300 264p.
440 0 Cancer drug discovery and development
650 0 Antineoplastic agents|xDevelopment.
650 0 Proteomics|xMethodology.
650 0 Cancer|xMolecular aspects.
